Search results for: France
Filter search results
NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?
18 September 2023
…and Care Excellence (NICE) decision outcomes on healthcare decision-making in 12 countries across the globe (Australia, Brazil, Canada, France, Italy, Israel, Japan, South Korea, Poland, Saudi Arabia, Sweden, and the…
Politics of Prescribing
1 January 1985
…pharmaceutical innovation. The other six are the United States, West Germany, Switzerland, France,… This briefing is based on a lecture given by George Teeling Smith. At present Britain is one…
Patient Preferences for Diagnostic Tests Aimed at Managing Antimicrobial Resistance
7 October 2019
…This research involved survey participants from the United Kingdom (UK), Germany, Spain, France, the Netherlands, Greece, and Italy who had used antibiotics in the previous two years. This is the…
Should Drug Prices Differ by Indication? The Debate on Indication-based Pricing
11 May 2018
…France, Germany, Italy, Spain and the UK. The “debate” around IBP centres on i) who benefits and who loses? and ii) how and whether it can be implemented in…
OHE at ISPOR Italy Chapter – Rome: Are Wider Societal Effects Considered in Healthcare Decision-making?
17 May 2016
…Considered in Healthcare Decision-making? An overview from other countries from Office of Health Economics There were three further presentations at the conference given by: Professor Francesco Saverio Mennini, President of…
The Expanding Value Footprint of Oncology Treatments
1 May 2014
…treatment regimen, or patient population or subpopulation. The decisions of three entities were included in the study: the Haute Autorité de Santé (HAS) in France, NICE in England and Wales,…
Understanding the Full Value of Long-Acting Therapies: less is more?
7 May 2025
…often overlooked. Countries with more flexible HTA frameworks, like Canada and the UK, are better positioned to capture these broader value elements than others like Germany and France. Stakeholder collaboration…
New OHE Study Compares Decisions by Five HTA Agencies on Oncology Meds
31 January 2013
…in a selection of industrialised countries: Australia, Canada, France, Scotland, and the United Kingdom (England and Wales). The aims of the study are to identify the key determinants of decisions…
The Impact of Behavioural and Biomedical Advance on Health Trends over the Next 25 Years
11 January 1994
…reports dealt with France, the former West Germany and the United Kingdom respectively (Andersson et al, 1992; Andersson etal, 1993; Oleksy etal, 1994). The US study was commissioned by the…